Drawing for EASYXPRESS

USPTO serial 79003301

EASYXPRESS

Reviewed by CopyMark Law Group

Reg. 3567797Status 404
Filing date
Status date
Registration date
Jan 27, 2009
Examiner
SHARPER JR, SAM
Law office

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EASYXPRESS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roxana A. Sullivan

Roxana A. Sullivan Dennemeyer & Associates, LLC.120 South LaSalle Street, Suite 1400Chicago, IL 60603UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical products for scientific and commercial use, comprising [ chemicals for performing Polymerase Chain Reaction (PCR), ] chemicals for performing in-vitro protein syntheses, namely, in-vitro transcription and in-vitro translation, namely, nucleic acids, oligonucleotides, deoxynucleosides, buffer solutions, salt, enzymes, prokaryotic and eukaryotic cell lysates; kits containing chemical products for scientific and commercial use, comprising [ chemicals for performing Polymerase Chain Reaction (PCR), ] chemicals for performing in-vitro protein syntheses namely, in-vitro transcription and in-vitro translation, namely, nucleic acids, oligonuceotides, deoxynucleosides, buffer solutions, salt, enzymes, prokaryotic and eukaryotic cell lysatesSECTION 71 - CANCELLED
005[ Diagnostic agents for human-medical and veterinary use, comprising chemicals for performing Polymerase Chain Reaction (PCR), chemicals for performing in-vitro protein syntheses namely, in-vitro transcription and in-vitro translation, namely, nucleic acids, oligonucleotides, deoxynucleosides, buffer solutions, enzymes, salt, prokaryotic and eukaryotic cell lysates; diagnostic kits containing chemical products for diagnostic use, comprising chemicals for performing Polymerase Chain Reaction (PCR), chemicals for performing in-vitro protein syntheses, namely, in-vitro transcription and in-vitro translation, namely, nucleic acid, oligonucleotides, ceoxynucleosides, buffer solutions, enzymes, salt, prokaryotic and eukaryotic cell lysates ]SECTION 71 - CANCELLED
009Kits for performing and evaluating [ Polymerase Chain Reaction PCR, ] in-vitro transcription and in-vitro translation as well as for the separation, purification and/or isolation of substances, comprising laboratory equipment, namely, tubes, filters, multi-well [ olates ] * plates * [, magnetic beads, magnetic separators and pipettes ]SECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jul 13, 2024DETHDEATH OF INTERNATIONAL REGISTRATION
Jul 10, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jun 12, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 11, 2020INPCINVALIDATION PROCESSED
Apr 30, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 30, 2019C71TCANCELLED SECTION 71
Jan 27, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 24, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Feb 28, 2017INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 5, 2016INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 5, 2016INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 5, 2016INPCINVALIDATION PROCESSED
Jan 1, 2016INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 1, 2015NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 1, 2015C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
May 1, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 17, 2015ES75TEAS SECTION 71 & 15 RECEIVED
Jan 3, 2014RNWLINTERNATIONAL REGISTRATION RENEWED
Jan 5, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 1, 2011NREPNEW REPRESENTATIVE AT IB RECEIVED
May 8, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB
May 8, 2009FIMPFINAL DISPOSITION PROCESSED
Apr 27, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 27, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 18, 2008TMBNTTAB RELEASE CASE TO TRADEMARKS
Dec 18, 2008OP.TOPPOSITION TERMINATED NO. 999999
Dec 18, 2008OP.DOPPOSITION DISMISSED NO. 999999
Jul 23, 2008MAILPAPER RECEIVED
May 25, 2006ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 13, 2006RFNPREFUSAL PROCESSED BY IB
Apr 13, 2006OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 22, 2006OP.IOPPOSITION INSTITUTED NO. 999999
Mar 21, 2006OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Mar 21, 2006OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED
Jan 6, 2006OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 15, 2005OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 15, 2005OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 19, 2005ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Sep 20, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 31, 2005NPUBNOTICE OF PUBLICATION
Jun 3, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
May 11, 2005ALIEASSIGNED TO LIE
Apr 27, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Apr 27, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Apr 4, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2005MAILPAPER RECEIVED
Mar 3, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2005MAILPAPER RECEIVED
Oct 8, 2004RFNTREFUSAL PROCESSED BY IB
Sep 3, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2004DOCKASSIGNED TO EXAMINER
Jul 19, 2004NWAPNEW APPLICATION ENTERED
Jul 15, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance